Rhumbline Advisers Moderna, Inc. Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

A detailed history of Rhumbline Advisers transactions in Moderna, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 622,857 shares of MRNA stock, worth $17.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
622,857
Previous 597,467 4.25%
Holding current value
$17.4 Million
Previous $16.9 Million 1.45%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$23.65 - $28.54 $600,473 - $724,630
25,390 Added 4.25%
622,857 $17.2 Million
Q1 2025

Apr 08, 2025
BUY
$28.35 - $47.53 $2.05 Million - $3.44 Million
72,464 Added 13.8%
597,467 $16.9 Million
Q4 2024

May 29, 2025
SELL
$36.85 - $63.93 $2.67 Million - $4.63 Million
-72,464 Reduced 12.13%
525,003 $21.8 Million
Q4 2024

Jan 30, 2025
SELL
$36.85 - $63.93 $770,238 - $1.34 Million
-20,902 Reduced 3.83%
525,003 $21.8 Million
Q3 2024

Nov 12, 2024
SELL
$63.64 - $125.14 $2.55 Million - $5.02 Million
-40,087 Reduced 6.84%
545,905 $36.5 Million
Q2 2024

Aug 01, 2024
SELL
$101.21 - $166.61 $293,509 - $483,169
-2,900 Reduced 0.49%
585,992 $69.6 Million
Q1 2024

May 09, 2024
BUY
$85.37 - $115.44 $406,446 - $549,609
4,761 Added 0.82%
588,892 $62.8 Million
Q4 2023

Feb 08, 2024
SELL
$69.51 - $104.43 $228,062 - $342,634
-3,281 Reduced 0.56%
584,131 $58.1 Million
Q3 2023

Nov 09, 2023
BUY
$96.41 - $126.61 $590,704 - $775,739
6,127 Added 1.05%
587,412 $60.7 Million
Q2 2023

Aug 08, 2023
BUY
$118.5 - $160.53 $14,694 - $19,905
124 Added 0.02%
581,285 $70.6 Million
Q1 2023

May 11, 2023
SELL
$135.66 - $197.02 $1 Million - $1.46 Million
-7,394 Reduced 1.26%
581,161 $89.3 Million
Q4 2022

Feb 14, 2023
BUY
$118.38 - $210.04 $1.47 Million - $2.61 Million
12,421 Added 2.16%
588,555 $106 Million
Q3 2022

Nov 10, 2022
BUY
$118.07 - $194.18 $670,047 - $1.1 Million
5,675 Added 0.99%
576,134 $68.1 Million
Q2 2022

Aug 11, 2022
BUY
$117.13 - $176.59 $1.95 Million - $2.93 Million
16,608 Added 3.0%
570,459 $81.5 Million
Q1 2022

May 12, 2022
BUY
$126.46 - $235.05 $3.28 Million - $6.1 Million
25,931 Added 4.91%
553,851 $95.4 Million
Q4 2021

Feb 10, 2022
BUY
$225.82 - $368.51 $3.86 Million - $6.29 Million
17,074 Added 3.34%
527,920 $134 Million
Q3 2021

Nov 12, 2021
BUY
$221.9 - $484.47 $36.5 Million - $79.7 Million
164,555 Added 47.52%
510,846 $197 Million
Q2 2021

Aug 05, 2021
BUY
$129.91 - $234.98 $3.47 Million - $6.28 Million
26,740 Added 8.37%
346,291 $81.4 Million
Q1 2021

May 06, 2021
BUY
$109.18 - $185.98 $192,811 - $328,440
1,766 Added 0.56%
319,551 $41.8 Million
Q4 2020

Feb 10, 2021
SELL
$65.74 - $169.86 $249,483 - $644,618
-3,795 Reduced 1.18%
317,785 $33.2 Million
Q3 2020

Nov 12, 2020
BUY
$54.34 - $94.85 $174,159 - $303,994
3,205 Added 1.01%
321,580 $22.8 Million
Q2 2020

Aug 13, 2020
BUY
$29.67 - $80.0 $2.56 Million - $6.91 Million
86,381 Added 37.23%
318,375 $20.4 Million
Q1 2020

May 06, 2020
BUY
$17.78 - $31.58 $728,251 - $1.29 Million
40,959 Added 21.44%
231,994 $6.95 Million
Q4 2019

Feb 05, 2020
BUY
$13.93 - $21.28 $290,259 - $443,411
20,837 Added 12.24%
191,035 $3.74 Million
Q3 2019

Oct 23, 2019
BUY
$12.26 - $18.07 $1.69 Million - $2.49 Million
137,924 Added 427.35%
170,198 $2.71 Million
Q2 2019

Aug 14, 2019
BUY
$13.7 - $28.34 $225,981 - $467,468
16,495 Added 104.54%
32,274 $472,000
Q1 2019

May 01, 2019
BUY
$14.45 - $23.7 $228,006 - $373,962
15,779 New
15,779 $321,000

Others Institutions Holding MRNA

# of Institutions
861
Shares Held
267M
Call Options Held
28.5M
Put Options Held
34.8M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email